Oppenheimer & CO Inc Cooper Companies, Inc. Transaction History

Oppenheimer & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$248.67 - $334.17 $326,006 - $438,096	-1,311 Reduced 64.87%	710 $234,000
Q3 2022 Nov 14, 2022	BUY	$263.81 - $337.27 $16,356 - $20,910	62 Added 3.16%	2,021 $533,000
Q2 2022 Aug 08, 2022	BUY	$301.4 - $428.42 $35,866 - $50,981	119 Added 6.47%	1,959 $613,000
Q1 2022 May 12, 2022	BUY	$379.46 - $424.54 $698,206 - $781,153	1,840 New	1,840 $768,000
Q2 2018 Aug 10, 2018	SELL	$217.98 - $237.23 $497,430 - $541,358	-2,282 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$218.74 - $251.43 $12,468 - $14,331	-57 Reduced 2.44%	2,282 $522,000
Q4 2017 Feb 07, 2018	SELL	$217.88 - $244.43 $56,430 - $63,307	-259 Reduced 9.97%	2,339 $510,000
Q3 2017 Nov 09, 2017	BUY	$231.6 - $253.39 $601,696 - $658,307	2,598	2,598 $616,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.